<SEC-DOCUMENT>0001209191-22-043130.txt : 20220725
<SEC-HEADER>0001209191-22-043130.hdr.sgml : 20220725
<ACCEPTANCE-DATETIME>20220725170645
ACCESSION NUMBER:		0001209191-22-043130
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20220715
FILED AS OF DATE:		20220725
DATE AS OF CHANGE:		20220725

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Brown Martin S JR
		CENTRAL INDEX KEY:			0001362521

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		221104209

	MAIL ADDRESS:	
		STREET 1:		850 DIXIE HIGHWAY
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40210

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2022-07-15</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001087294</issuerCik>
        <issuerName>CUMBERLAND PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>CPIX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001362521</rptOwnerCik>
            <rptOwnerName>Brown Martin S JR</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2525 WEST END AVENUE, SUITE 950</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NASHVILLE</rptOwnerCity>
            <rptOwnerState>TN</rptOwnerState>
            <rptOwnerZipCode>37203</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes></footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Martin S. Brown, Jr. by /s/ John Hamm as attorney-in-fact</signatureName>
        <signatureDate>2022-07-25</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>poa.txt
<DESCRIPTION>POA DOCUMENT
<TEXT>
POWER OF ATTORNEY

Know all by these presents, I hereby appoint John Hamm to act as my agent and
attorney-in-fact for the purpose of completing, executing and filing on my
behalf with the Securities and Exchange Commission, the NASDAQ Stock Market LLC
or any other exchange or self-regulatory body, any Form 3 "Initial Statement of
Beneficial Ownership of Securities", Form 4 "Statement of Changes in Beneficial
Ownership of Securities", Form 5 "Annual Statement of Beneficial Ownership of
Securities", Form 144 "Notice of Proposed Sale of Securities", Schedule 13D
pursuant to Rule 13d-101 of the Securities Exchange Act of 1934, or any other
similar form to report securities ownership that may, in the opinion of any of
them be necessary, with respect to any transaction in securities of Cumberland
Pharmaceuticals Inc.

Nothing herein shall relieve me of the responsibility for the accuracy of the
information and representations contained in any Form 3, Form 4, Form 5, Form
144, Schedule 13D, or other similar form completed, executed and filed pursuant
to this power of attorney.

This power of attorney shall supersede all similar prior powers of attorney and
will remain effective as to the agents and attorneys-in-fact referred to above
until I revoke or amend it by written notice to such persons or until the
undersigned is no longer required to file Form 3, Form 4, Form 5, Form 144,
Schedule 13D or other similar form completed, executed and filed pursuant to
this power of attorney.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed on this 21st day of July 2022.




/s/ Martin S. Brown, Jr.

Martin S. Brown, Jr.


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
